Tracheobronchial Secretion Removal

University of Milano Bicocca

Status: Completed

Conditions: Respiration, Artificial; Respiratory Insufficiency

Treatments: Device: Control; Device: TBA care device

Study type: Interventional

Funder types: Other

Identifiers

NCT00932776

AR HSG 268

Details and patient eligibility

About

Patients undergoing intubation and mechanical ventilation require removal of secretion by means of trachoebronchial suctioning. Timing of the procedure is mainly based on clinical parameters. TBA Care® is a new commercially available device designed to generate a signal when secretions are present in the respiratory tract of intubated patients, thus indicating the need for endotracheal suctioning only when necessary and prior to clinical deterioration. In a prospective randomized trial in intubated and mechanically ventilated patients of a general ICU the researchers investigated the efficacy of TBA Care® in detecting the presence of retained secretions compared to the standard indicators.

Sex: Male

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age greater than 18 years
• presence of an endotracheal tube to provide mechanical ventilation
• expected duration of mechanical ventilation greater than 48 hours.

Exclusion criteria

• age < 18 years, pregnancy
• presence of active bronchial bleeding

Trial design

0 participants in 2 patient groups

TBA

Experimental group

Treatment:

Device: TBA care device

Control

Active Comparator group

Treatment:

Device: Control